BlackRock Investment Management’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

BlackRock Investment Management’s Portfolio TRIV Stock Details TRIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,639	Closed	-$11K	–	4169
2015 Q4	$11K	Buy	1,639 +52	+3%	+$345	﹤0.01%	3667
2015 Q3	$8K	Hold	1,587	–	–	﹤0.01%	3806
2015 Q2	$8K	Sell	1,587 -20,237	-93%	-$144K	﹤0.01%	3832
2015 Q1	$229K	Hold	21,824	–	–	﹤0.01%	3195
2014 Q4	$274K	Buy	21,824 +64	+0.3%	+$873	﹤0.01%	3200
2014 Q3	$315K	Buy	+21,760	New	+$316K	﹤0.01%	3164

BlackRock Investment Management's TRIV Position: Q1 2016 in Review

BlackRock Investment Management sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 1,639 shares — an estimated $11K sold.

BlackRock Investment Management first reported a position in TRIV in Q3 2014 and held it in 6 quarters. The position peaked at $315K in Q3 2014. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

BlackRock Investment Management reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
BlackRock Investment Management sold 1,639 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $11K.
BlackRock Investment Management first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q3 2014 and held it in 6 quarters.
BlackRock Investment Management's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $315K in Q3 2014.
0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on BlackRock Investment Management's 13F filing for Q1 2016, filed 10 May 2016.